ClinicalTrial | Financial Buzz

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Regeneron Set to Request FDA Approval to Use Covid Antibody Drug as a Preventative Treatment

Rebecca Urena04/12/202104/12/2021

3255

Regeneron Pharmaceuticals (NASDAQ: REGN) announced Monday that it is prepared to ask the Food and Drug Administration for approval to use its Covid-19 antibody therapy as a preventative treatment....

Biotechnology Breaking News Healthcare Investing News Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Affimed N.V (NASDAQ: AFMD) Announces Positive Initial Clinical Data

financial buzz04/09/2021

2165

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Affimed N.V Announces Positive Initial Clinical Data” Affimed N.V. (NASDAQ: AFMD) surged over 30% in premarket trading after...

Biotechnology Breaking News Healthcare Market News Technology The Buzz The Buzz TV The Market Buzz Top Videos Video

“The Buzz” Show: Entera Bio Ltd. (NASDAQ: ENTX) Positive Topline EB613 Phase 2 Biomarker Data

financial buzz03/11/2021

1707

FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Entera Bio Ltd Announces Positive Topline EB613 Phase 2 Biomarker Data” Entera Bio Ltd (NASDAQ: ENTX) surged over...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Entera Bio Reports Positive Phase 2 Results

Danny Abramov03/11/2021

4112

Entera Bio Ltd. (NASDAQ: ENTX) reported 3 months of results on their ongoing Phase 2 clinical trial of EB613, the company’s orally delivered human parathyroid hormone. Positioned to be...

Breaking News Buzz On The Street Healthcare Market News Medical Use Pharmaceutical Products Recreational Use Technology The Buzz TV The Market Buzz Top Videos Video

“Buzz on the Street” Show: HempFusion (OTCQX: CBDHF) (TSX: CBD.U) CBD Clinical Trial at Mount Sinai

financial buzz02/17/202103/04/2021

6713

FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New...

Breaking News Cannabis Buzz Healthcare Investing News Market News Medical Use Pharmaceutical Products Recreational Use The Market Buzz

Breaking News: HempFusion CBD to be the Exclusive Supplier for Clinical Trial at Mount Sinai Medical Hospital, New York

financial buzz02/17/2021

4961

HempFusion Wellness Inc. (OTCQX: CBDHF) (TSX: CBD.U) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to...

Biotechnology Healthcare Investing News Life Style Market News Medical Use Pharmaceutical Products The Market Buzz Your Environment

Veru Reveals Cancer Drug Could Reduce Covid-19 Deaths

Rebecca Urena02/09/202102/09/2021

2378

Veru (NASDAQ: VERU), an Oncology Biopharmaceutical Company, skyrocketed to double digits after reporting beneficial data regarding a cancer drug which could combat Covid-19. “We are very pleased with the...

Healthcare Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

J&J Single-Dose Covid Vaccine 66% Effective

Rebecca Urena01/29/202101/29/2021

3048

Johnson & Johnson (NYSE: JNJ) announced Friday that its single-dose coronavirus vaccine was currently 66% effective against Covid-19. Nevertheless, the vaccine seems to be less efficient when it comes...

Biotechnology Healthcare Investing News Market News Technology The Market Buzz

Aptorum Group Obtains Clearance from Health Canada to Begin Phase 1 Clinical Trial for ALS-4, Small Molecule Drug for Infections Due to Staphylococcus Aureus

Nikita Medvedev01/20/2021

2560

Aptorum Group Limited (NASDAQ: APM) receives clearance from the Public Health Agency of Canada in regards to its Clinical Trial Application to begin Phase 1 study of ALS-4, its...

Investing News Life Style Market News Medical Use Pharmaceutical The Market Buzz Your Environment

Eli Lilly Announces Positive Results for its Alzheimer’s Drug

Rebecca Urena01/11/202101/11/2021

2251

Eli Lilly (NYSE: LLY), an American pharmaceutical company, announced on Monday that its experimental Alzheimer’s drug donanemab has proven to slow the disease by about a third the rate...

Tag: ClinicalTrial